Human Immunodeficiency Viruses in The Developing World

Advances in Virus Research

Volumn 53, Issue C, 1999, Pages 71-88

  Essex, Max ^a  

^a Harvard AIDS Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; DEVELOPING COUNTRY; DISEASE TRANSMISSION; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR EVOLUTION; PATHOGENICITY; REVIEW; VIRUS GENOME;

ANIMALS; DEVELOPING COUNTRIES; DISEASE TRANSMISSION, HORIZONTAL; DISEASE TRANSMISSION, VERTICAL; EVOLUTION, MOLECULAR; GENOME, VIRAL; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; RECOMBINATION, GENETIC; VARIATION (GENETICS);

EID: 0033257958     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/S0065-3527(08)60343-7     Document Type: Article

References (72)

1. Clumeck, N., Mascart Lemone, F., de Maubeuge, J., Brenez, D., Marcells, L., Acquired immune deficiency syndrome in black Africans. Lancet, 1, 1983, 642.
2. Essex, M., McLane, M.F., Lee, T.H., Falk, L., Howe, C.W.S., Mullins, J.I., Cabradilla, C., Francis, D.P., Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS. Science 220 (1983), 859–862.
3. Gelmann, E.P., Popovic, M., Blayney, D., Masur, H., Sidhu, G., Stahl, R.E., Gallo, R.C., Proviral DNA of a retrovirus, human T-cell leukemia virus, in two patients with AIDS. Science 220 (1983), 862–865.
4. Barre-Sinoussi, F., Chermann, J.-C., Rey, F., Isolation of T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220 (1983), 868–871.
5. Kanki, P.J., McLane, M.F., King, N.W.J., Letvin, N.L., Hunt, R.D., Sehgal, P., Daniel, M.D., Desrosiers, R.C., Essex, M., Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science 228 (1985), 1199–1201.
6. Murphey-Corb, M., Martin, L.N., Rangan, S.R., Baskin, G.B., Gormus, B.J., Wolf, R.H., Andes, W.A., West, M., Montelaro, R.C., Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature (London) 321 (1986), 435–437.
7. Kanki, P.J., Kurth, R., Becker, W., Dreesman, G., McLane, M.F., Essex, M., Antibodies to simian T-lymphotropic retrovirus type III in African green monkeys and recognition of STLV-III viral proteins by AIDS and related sera. Lancet 1 (1985), 1330–1332.
8. Peeters, M., Honore, C., Huet, T., Bedjabaga, L., Ossari, S., Bussi, P., Cooper, R.W., Delaporte, E., Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon. AIDS 3 (1989), 625–630.
9. Essex, M., Kanki, P.J., The origins of the AIDS virus. Sci. Am. 259 (1988), 64–71.
10. Piot, P., Goeman, J., Laga, M., The epidemiology of HIV and AIDS in Africa. Essex, M., Mboup, S., Kanki, P.J., Kalengayi, M.R., (eds.) ‘AIDS in Africa’, 1994, Raven Press, New York, 157–171.
11. Essex, M., Origin of acquired immunodeficiency syndrome. DeVita, V.T. Jr., Hellman, S., Rosenberg, S.A., Curran, J., Essex, M., Fauci, A.S., (eds.) ‘AIDS, Biology, Diagnosis, Treatment and Prevention’, 1997, Lippincott, Philadelphia, 3–14.
12. Nahmias, A.J., Weiss, J., Yao, X., Lee, F., Kodsi, R., Schanfield, M., Matthews, T., Bolognesi, D., Durack, D., Motulsky, A., Kanki, P., Essex, M., Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959. Lancet 1 (1986), 1279–1280.
13. Barin, F., McLane, M.F., Allan, J.S., Lee, T.H., Groopman, J.E., Essex, M., Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science 228 (1985), 1094–1096.
14. Essex, M., Kanki, P., Human immunodeficiency virus type 2 (HIV-2). Broder, S., Merigan, T., Bolognesi, D., (eds.) ‘Textbook of AIDS Medicine’, 1994, Williams & Wilkins, Baltimore, MD, 873–886.
15. Yu, Q.-C., Matsuda, Z., Yu, X.-F., Ito, S., Essex, M., Lee, T.H., An electronlucent region within the virion distinguishes human immunodeficiency virus (HIV) type 1 from HIV-2 and simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 10 (1994), 745–749.
16. Yu, X.-F., Ito, S., Essex, M., Lee, T.H., A naturally immunogenic virion-associated protein specific for HIV-2 and SIV. Nature (London) 335 (1988), 262–265.
17. Matsuda, Z., Chou, M.J., Matsuda, M., Huang, J.H., Chen, Y.M., Redfield, R., Mayer, K., Essex, M., Lee, T.H., Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome. Proc. Natl. Acad. Sci. U.S.A. 85 (1988), 6968–6972.
18. Arya, S., Gallo, R., Human immunodeficiency virus type 2 long terminal repeat: Analysis of regulatory elements. AIDS 85 (1988), 9753–9757.
19. Tong-Starksen, S., Welsh, T., Peterlin, M., Differences in transcriptional enhancers of HIV-1 and HIV-2 response to T-cell activation signals. J. Immunol. 145 (1990), 4348–4354.
20. Markovitz, D.M., Hannibal, M., Perez, V.L., Gauntt, C., Folks, T.M., Nabel, G.J., Differential regulation of human immunodeficiency viruses (HIVs): A specific regulatory element in HIV-2 responds to stimulation of the T-cell antigen receptor. Proc. Natl. Acad. Sci. U.S.A. 87 (1990), 9098–9102.
21. Kanki, P.J., Travers, K.M., Boup, S., Hsieh, C.-C., Marlink, R.G., Guèye-NDiaye, A., Siby, T., Thior, I., Hernandez Avila, M., Sankalé, J.-L., Ndoye, I., Essex, M.E., Slower heterosexual spread of HIV-2 than HIV-1. Lancet 343 (1994), 943–946.
22. Gayle, H., Gnaore, E., Adjorlolo, G., Ekpini, E., Coulibaly, R., Porter, A., Braun, M.M., Zabban, M.L., Andou, J., Timite, A., HIV-1 and HIV-2 infection in children in Abidjan, Côte D'Ivoire. J. Acquired Immune Defic. Syndr. 5 (1992), 513–517.
23. Del Mistro, A., Chotard, J., Mali, A., Whittle, H., de Rossi, A., Chieco-Bianchi, L., HIV-1 and HIV-2 seroprevalence rates in mother-child pairs living in The Gambia, West Africa. J. Acquired Immune Defic. Syndr. 5 (1992), 19–24.
24. Marlink, R., Kanki, P., Thior, I., Travers, K., Eisen, G., Siby, T., Traore, I., Hsieh, C.-C., Dia, M.C., Gueye, E.-H., Hellinger, J., Guèye-Ndiaye, A., Sankalé, J.-L., Ndoye, I., Mboup, S., Essex, M., Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265 (1994), 1587–1590.
25. Moore, J.P., Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-2 for soluble CD4. AIDS 4 (1990), 297–305.
26. Mulligan, M.J., Kumar, P., Hui, H.X., Owens, R.J., Ritter, G.D.J., Hahn, B.H., Compans, R.W., The env protein of an infectious noncytopathic HIV-2 is deficient in syncytium formation. AIDS Res. Hum. Retroviruses 6 (1990), 707–720.
27. Simon, F., Matheron, S., Tamalet, C., Loussert-Ajaka, I., Bartczak, S., Pepin, J.M., Dhiver, C., Gamba, E., Elbim, C., Gastaut, J.A., Cellular and plasma viral load in patients infected with HIV-2. AIDS 7 (1993), 1411–1417.
28. Guèye-Ndiaye, A., Clark, R.J., Samuel, K.P., Ndour-Sarr, A.N., Ouangré, A., Sangaré, L.M., Boup, S., Marlink, R.G., Papas, T.S., Child, R.H., Coll-Seck, A.M., Essex, M.E., Kanki, P.J., Cost-effective diagnosis of HIV-1 and HIV-2 by recombinant-expressed env peptide (566/996). dot blot analysis. AIDS 7 (1993), 475–481.
29. Travers, K.M., Boup, S., Marlink, R., Guèye-Ndiaye, A., Siby, T., Thior, I., Traore, I., Dieng-Sarr, A., Sankalé, J.-L., Mullins, C., Ndoye, I., Hsieh, C.-C., Essex, M., Kanki, P., Natural protection against HIV-1 infection provided by HIV-2. Science 268 (1995), 1612–1615.
30. Preston, B.D., Poiesz, B.J., Loeb, L.A., Fidelity of HIV-1 reverse transcriptase. Science 242 (1988), 1168–1171.
31. Myers, G., Pavlakis, G.N., Evolutionary potential of complex retroviruses. Levy, J., (eds.) ‘The Retroviridae’, 151, 1992, Plenum, New York.
32. Smith, T.F., Srinivasan, A., Schochetman, G., Marcus, M., Myers, G., The phylogenetic history of immunodeficiency viruses. Nature (London) 333 (1988), 573–575.
33. Louwagie, J., McCutchan, F., Van der Groen, G., Peeters, M., Fransen, K., Piot, P., Gershy-Damet, G.M., Roelants, G., van Heuverswyn, H., Eddy, G., Genetic comparison of HIV-1 isolates from Africa, Europe, and North America. AIDS Res. Hum. Retroviruses 8 (1992), 1467–1469.
34. Essex, M., Retroviral vaccines: Challenges for the developing world. AIDS Res. Hum. Retroviruses 12 (1996), 361–363.
35. Weniger, B.G., Takebe, Y., Ou, C.-Y., Yamazaki, S., The molecular epidemiology of HIV in Asia. AIDS 8:Suppl. 2 (1994), S13–S28.
36. Subbarao, S., Limpakarnjanarat, K., Mastro, T.D., Bhumisawasdi, J., Warachit, P., Jayavasu, C., Young, N.L., Luo, C., Shaffer, N., Kalish, M.L., Schochetman, G., HIV Type 1 in Thailand, 1994–1995: Persistence of two subtypes with low genetic diversity. AIDS Res. Hum. Retroviruses 14 (1998), 319–327.
37. Shafer, R.W., Eisen, J.A., Mergan, T.C., Katzenstein, D.A., Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe. J. Virol. 71 (1997), 5441–5448.
38. Renjifo, B., Chaplin, B., Mwakagile, D., Shah, P., Vannberg, F., Msamanga, G., Hunter, D., Fawzi, W., Essex, M., Epidemic expansion of HIV-1 subtype C and recombinant genotypes in Tanzania. AIDS Res. Hum. Retroviruses 14 (1998), 635–638.
39. Janssens, W., Buve, A., Nkengasong, J.N., The puzzle of subtypes in Africa. AIDS 11 (1997), 705–712.
40. Mertens, T., Piot, P., Global aspects of human immunodeficiency virus epidemiology: General considerations. DeVita, V.T. Jr., Hellman, S., Rosenberg, S.A., Curran, J., Essex, M., Fauci, A.S., (eds.) ‘AIDS, Biology, Diagnosis, Treatment and Prevention’, 1997, Lippincott, Philadelphia, 103–118.
41. Burke, D.S., McCutchan, F.E., Global distribution of human immunodeficiency virus-1 Clades. DeVita, V.T. Jr., Hellman, S., Rosenberg, S.A., Curran, J., Essex, M., Fauci, A.S., (eds.) ‘AIDS, Biology, Diagnosis, Treatment and Prevention’, 1997, Lippincott, Philadelphia, 119–126.
42. Tersmette, M., Lange, J.M., de Goede, R.E., de Wolf, F., Eeftink-Schattenkerk, J.K., Schellekens, P.T., Coutinho, R.A., Huisman, J.G., Goudsmit, J., Miedema, F., Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1 (1989), 983–985.
43. Shioda, T., Levy, J.A., Cheng-Mayer, C., Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 89 (1992), 9434–9438.
44. Supparatpinyo, K., Khamwan, C., Baosoung, V., Nelson, K.E., Sirisanthana, T., Disseminated Penicillium marneffei infection in southeast Asia. Lancet 344 (1994), 110–113.
45. Cooper, D.A., Gold, J., Maclean, P., Donovan, B., Finlayson, R., Barnes, T.G., Michelmore, H.M., Brooke, P., Penny, R., Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet 1 (1985), 537–540.
46. Pantaleo, G., Graziosi, C., Demarest, J.F., Butini, L., Montroni, M., Fox, C.H., Orenstein, J.M., Kotler, D.P., Fauci, A.S., HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 362 (1993), 355–358.
47. Embretson, J., Zupancic, M., Ribas, J.L., Burke, A., Racz, P., Tenner-Racz, K., Haase, A.T., Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 362 (1993), 359–362.
48. Royce, R.A., Sena, A., Cates, W.J., Cohen, M.S., Sexual transmission of HIV. N. Engl. J. Med. 336 (1997), 1072–1078.
49. John, G.C., Nduati, R.W., Mbori, N.D., Overbaugh, J., Welch, M., Richardson, B.A., Ndinya-Achola, J., Bwayo, J., Krieger, J., Onyango, F., Kreiss, J.K., Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: Association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J. Infect. Dis. 175 (1997), 57–62.
50. Zorr, B., Schafer, A.P., Dilger, I., Habermehl, K.O., Kosh, M., HIV-1 detection in endocervical swabs and mode of HIV-1 infection (letter). Lancet, 343, 1994, 852.
51. Critchlow, C.W., Kiviat, N.B., Detection of human immunodeficiency virus type 1 and type 2 in the female genital tract: Implications for the understanding of virus transmission. Obstet. Gynecol. Surv. 52 (1997), 315–324.
52. Zhu, T., Wang, N., Carr, A., Nam, D.S., Moor-Jankowski, R., Cooper, D.A., Ho, D.D., Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: Evidence for viral compartmentalization and selection during sexual transmission. J. Virol. 70 (1996), 3098–3107.
53. de Vincenzi, I., A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N. Engl. J. Med. 331 (1994), 341–346.
54. Jessamine, P.G., Ronald, A.R., Chancroid and the role of genital ulcer disease in the spread of human retroviruses. Med. Clin. North Am. 74 (1990), 1417–1431.
55. Plourde, P.J., Plummer, F.A., Pepin, J., Agoki, E., Moss, G., Ombette, J., Ronald, A.R., Cheang, M., D'Costa, L., Ndinya-Achola, J.O., Human immunodeficiency virus type 1 infection in women attending a sexually transmitted diseases clinic in Kenya. J. Infect. Dis. 166 (1992), 86–92.
56. Soto-Ramirez, L.E., Renjifo, B., McLane, M.F., Marlink, R., O'Hara, C., Sutthent, R., Wasi, C., Vithayasai, P., Vithayasai, V., Apichartpiyakul, C., Auewarakul, P., Pena Cruz, V., Chui, D.S., Osathanondh, R., Mayer, K., Lee, T.H., Essex, M., HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 271 (1996), 1291–1293.
57. Lehner, T., Hussain, L., Wilson, J., Chapman, M., Mucosal transmission of HIV (letter; comment). Nature (London), 353, 1991, 709.
58. Blauvelt, A., Asada, H., Saville, M.W., Klaus-Kovtun, V., Altman, D.J., Yarchoan, R., Katz, S.I., Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways. J. Clin. Invest. 100 (1997), 2043–2053.
59. Tscherning, C., Alaeus, A., Fredriksson, R., Bjorndal, A., Deng, H., Littman, D.R., Fenyo, E.M., Albert, J., Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 241 (1998), 181–188.
60. Briant, L., Wade, C.M., Puel, J., Brown, A.J., Guyader, M., Analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1. J. Virol. 69 (1995), 3778–3788.
61. Wolinsky, S.M., Wike, C.M., Korber, B.T., Hutto, C., Parks, W.P., Rosenblum, L.L., Kunstman, K.J., Furtado, M.R., Munoz, J.L., Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 255 (1992), 1134–1137.
62. Ahmad, N., Baroudy, B.M., Baker, R.C., Chappey, C., Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J. Virol. 69 (1995), 1001–1012.
63. Kampinga, G.A., Simonon, A., van de Perre, P., Karita, E., Msellati, P., Goudsmit, J., Primary infections with HIV-1 of women and their offspring in Rwanda: Findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. Virology 227 (1997), 63–76.
64. Scarlatti, G., Hodara, V., Rossi, P., Muggiasca, L., Bucceri, A., Albert, J., Fenyo, E.M., Transmission of human immunodeficiency virus type (HIV-1) from mother to child correlates with viral phenotype. Virology 197 (1993), 624–629.
65. Lewis, P., Nduati, R., Kreiss, J.K., John, G.C., Richardson, B.A., Mbori-Ngacha, D., Ndinya-Achola, J., Overbaugh, J., Cell-free human immunodeficiency virus type 1 in breast milk. J. Infect. Dis. 177 (1998), 34–39.
66. Nduati, R.W., John, G.C., Richardson, B.A., Overbaugh, J., Welch, M., Ndinya-Achola, J., Moses, S., Holmes, K., Onyango, F., Kreiss, J.K., Human immunodeficiency virus type 1-infected cells in breast milk: Association with immunosuppression and vitamin A deficiency. J. Infect. Dis. 172 (1995), 1461–1468.
67. Montano, M.A., Novitsky, V.A., Blackard, J.T., Cho, N.L., Katzenstein, D.A., Essex, M., Divergent transcriptional regulation among expanding HIV-1 subtypes. J. Virol. 71 (1997), 8657–8665.
68. Anderson, D.J., Politch, J.A., Tucker, L.D., Fichorova, R., Haimovici, F., Tuomala, R.E., Mayer, K.H., Quantitation of mediators of inflammation and immunity in genital tract secretions and their relevance to HIV type 1 transmission. AIDS Res. Hum. Retroviruses 14 (1988), 43–49.
69. Montano, M., Nixon, C., Essex, M., Dysregulation through the NF-κB enhancer and TATA box of the HIV-1 subtype E promoter. J. Virol. 72 (1998), 8446–8452.
70. Robertson, D.L., Sharp, P.M., McCutchan, F.E., Hahn, B.H., Recombination in HIV-1. Nature (London) 374 (1995), 124–126.
71. McCutchan, F.E., Hegerich, P., Brennan, T.P., Phanuphak, P., Singharaj, P., Jugsudee, A., Berman, P.W., Gray, A.M., Fowler, A.K., Burke, D.S., Genetic variants of HIV-1 in Thailand. AIDS Res. Hum. Retroviruses 8 (1992), 1887–1895.
72. Essex, M., Confronting the AIDS vaccine challenge. Technol. Rev. 97 (1994), 23–29.